Healthcare and Life Science
BioResource-supported study finds ongoing brain injury caused by COVID-19 may not always be detected by routine tests
A new study published in Nature Communications details that markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal. ...
NIHR BioResource Scientific Conference to return in June 2024
NIHR BioResource are excited to announce the NIHR BioResource Scientific Conference will return later this year, hosted online on Wednesday 19 June 2024 from 9.30am to 12.30pm. Leading academics and industry researchers will present their recent work and the unique role of the NIHR BioR...
International Day of Persons with Disabilities 2023 & reflection on our work with Purple Goat
In celebration of the International Day of Persons with Disabilities 2023 and Disability History Month, the BioResource would like to share some of the Diversity, Equity and Inclusion work we have been doing via our partnership with the inclusive marketing agency, Purple Goat. ...
Celebrating our Centres - Moorfields
This week, we hear from our colleagues at the NIHR BioResource Centre Moorfields in London about their rare and common eye disorders research. We also celebrate examples of recent progress and find out about the outcomes from a successful patient and public co-development project. ...
Elevating balance and vestibular care at angli-EAR Hearing with the arrival of James Saladine
angli-EAR Hearing proudly welcomes James Saladine, a highly experienced Balance and Vestibular Physiotherapist, to its expert team. With a background in Vestibular Rehabilitation Physiotherapy, James enhances the clinic's offerings, focusing on managing debilitating dizziness symptoms f...
Get to know the Governance and Ethics team at the NIHR BioResource
Who are they, what a day looks like in the team and everything involved in making our Governance and Ethics team one of the key resources as part of the NIHR BioResource! ...
CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies
Cambridge, UK, and Durham, North Carolina, US - CN Bio and Altis Biosystems, Inc., leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, announces a strategic partnership. ...
PlaqueTec and the Babraham Institute collaborate on phenotypic screen of coronary artery blood
Collaboration to develop a bespoke cell phenotyping assay for human blood Project aims to investigate cell types present in coronary artery samples from patients with CAD participating in PlaqueTec’s BIOPATTERN trial Assay will be available as a service in the Babraham Institute’s F...
Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases
· Clinical stage company formed from the merger of Oxitope Pharma and Arxx Therapeutics · Calluna Pharma has a pipeline of selective antibodies targeting immunological diseases · ...
Targeting annexin-A1 can halt cancer cell growth
New study shows effectiveness of first drug to focus on cancer-causing protein.